logo-loader
viewMarrone Bio Innovations

Marrone Bio reveals superior insect control results of next-generation nematicide and insecticide corn trials

The next-generation nematicide and insecticide has the potential to allow the company to expand its offerings to corn growers

Sunrise over a cornfield
The product in question was derived from Burkholderia rinojensis, a new special of soil bacterium that Marrone discovered

Marrone Bio Innovations (NASDAQ:MBII) announced the results of trials of its next-generation nematicide/insecticide, which showed a superior control of yield-robbing insects and nematodes in corn.

The Davis, California-based company conducted trials at six Midwest locations, which confirmed higher yields and cost-effective control of insects and nematodes equivalent to or better than current industry chemical standards, the company said.

The product in question was derived from Burkholderia rinojensis, a new special of soil bacterium that Marrone discovered. The series of six trials compares the new product with Majestene, a current MBI offering, and other current chemicals. The 2019 trials showed that the new product offers “outstanding control against corn rootworm larvae, seed corn maggot and lesion nematode in field corn.”

READ: Marrone Bio's biology-based seed treatments in Europe improved yields, cost effectively controlled soil insects

The new product is in the final phases of R&D development, the company said, and will be submitted for regulatory approval within the next year.

"These results speak to our ability to continue to mine and add value from our rich portfolio of microbes, cost effectively leveraging the capital invested in our R&D pipeline,” CEO Pamela Marrone said. “With this new product, we want to provide growers a breakthrough sustainable alternative that will provide greater efficacy while supporting their regenerative agriculture growing practices.”

Marrone currently markets soil treatment products in the US under the brand name Majestene for crops including potatoes, strawberries, tobacco, cucurbits and fruiting vegetables. The next-generation nematicide/insecticide has the potential to allow the company to expand its offerings to corn growers.

“Our latest field trials underscored the performance advantages of our next-generation insecticide/nematicide for three of the most pervasive pests in corn,” CCO Kevin Hammill said. “This gives us the potential to offer new options to our customers who are looking for high-performing, sustainable and cost-effective solutions to control these persistent yield-robbing insects in corn. This new product offering will expand our robust portfolio of seed, foliar and soil treatments, and enhance our market presence in row crops.”

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: Marrone Bio Innovations

Price: 1.18 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $164.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Marrone Bio Innovations receives approval from EPA for...

Marrone Bio Innovations (NASDAQ: MBII) CEO and Founder Dr Pam Marrone joined Steve Darling from Proactive Vancouver on Skype with news that two of its biofungicide products Stargus and Regalia have been approved by the U.S. Environmental Protection Agency for indoor and outdoor use on hemp...

on 01/07/2020

2 min read